tiprankstipranks
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market
RVPH
Reviva Pharmaceuticals Holdings
RESEARCH TOOLSreports
Want to see RVPH full AI Analyst Report?

Reviva Pharmaceuticals Holdings (RVPH) Financial Statements

1,209 Followers

Reviva Pharmaceuticals Holdings Financial Overview

Reviva Pharmaceuticals Holdings's market cap is currently $11.32M. The company's EPS TTM is $0.72; its P/E ratio is ―; Reviva Pharmaceuticals Holdings is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -20.20T$ -30.80M$ -39.50M$ -24.31M$ -10.10M
EBITDA$ -20.20T$ -29.88M$ -39.21M$ -24.11M$ -10.10M
Net Income$ -19.86T$ -29.92M$ -39.26M$ -24.34M$ -8.52M
Balance Sheet
Cash & Short-Term Investments$ 14.44T$ 13.48M$ 23.37M$ 18.52M$ 29.69M
Total Assets$ 15.92T$ 15.50M$ 23.70M$ 18.92M$ 31.40M
Total Debt$ 406.88B$ 458.15K$ 0.00$ 0.00$ 0.00
Net Debt$ -14.03T$ -13.02M$ -23.37M$ -18.52M$ -29.69M
Total Liabilities$ 7.28T$ 14.69M$ 17.98M$ 10.53M$ 2.72M
Stockholders' Equity$ 8.65T$ 812.57K$ 5.72M$ 8.39M$ 28.69M
Cash Flow
Free Cash Flow$ -24.59T$ -33.54M$ -28.32M$ -18.96M$ -10.67M
Operating Cash Flow$ -24.59T$ -33.54M$ -28.32M$ -18.96M$ -10.67M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 25.56T$ 23.65M$ 33.17M$ 7.79M$ 31.60M
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

Income Statement >

Reviva Pharmaceuticals Holdings Debt to Assets

Balance Sheet >

Reviva Pharmaceuticals Holdings Cash Flow

Cash Flow >

Reviva Pharmaceuticals Holdings Forecast EPS vs Actual EPS

Earnings >